186 related articles for article (PubMed ID: 17637539)
1. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
Wada Y; Otoshi M; Jitsuko A; Nishikawa H; Takahara S; Tsubono M; Imai S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1041-5. PubMed ID: 17637539
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer].
Kuroi K; Tanaka C; Bando H; Saji S; Hayashi K; Toi M
Gan To Kagaku Ryoho; 2002 Jan; 29(1):55-60. PubMed ID: 11816478
[TBL] [Abstract][Full Text] [Related]
4. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
[TBL] [Abstract][Full Text] [Related]
5. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
[TBL] [Abstract][Full Text] [Related]
8. [Weekly paclitaxel therapy for metastatic breast cancer].
Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
Kim R; Osaki A; Toge T
Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
[TBL] [Abstract][Full Text] [Related]
10. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma].
Ito S; Kodera Y; Mochizuki Y; Yamamura Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1427-30. PubMed ID: 16227742
[TBL] [Abstract][Full Text] [Related]
12. [Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
Nishimura H; Hamanaka K; Sakai H; Ohno Y; Miyagawa Y; Seki H; Munakata Y
Gan To Kagaku Ryoho; 2004 Apr; 31(4):627-30. PubMed ID: 15114714
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
[TBL] [Abstract][Full Text] [Related]
14. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
Kimura M; Koida T; Yanagita Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
Terauchi F; Nagashima T; Kobayashi Y; Yamamoto Y; Moritake T; Seiki T; Ogura H
Gan To Kagaku Ryoho; 2005 May; 32(5):641-4. PubMed ID: 15918564
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.
Hirai Y; Hasumi K; Onose R; Kuramoto H; Kuzuya K; Hatae M; Ochiai K; Nozawa S; Noda K
Gynecol Oncol; 2004 Aug; 94(2):471-6. PubMed ID: 15297190
[TBL] [Abstract][Full Text] [Related]
18. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of weekly paclitaxel administration for metastatic breast cancer based on time to progression (TTP) and survival].
Emoto T; Yoshikawa K; Yoshioka Y; Nezu R; Fujikawa M; Fujii M; Maeda S; Naka Y; Komaki T
Gan To Kagaku Ryoho; 2003 Jun; 30(6):817-22. PubMed ID: 12852349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]